Yazid N. Al Hamarneh

Author

Also Known As

Ross T. Tsuyuki, Y. Al Hamarneh, Y.N. Al Hamarneh, YN Al Hamarneh, Yazid Al Hamarneh, Yazid Al-Hamarneh, Yazid N Al Hamarneh, Yazid N. Al Hamarneh, Yazid N. Al Harmarneh, Yazid N. Alhamarneh

119

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Alberta University of Calgary University of British Columbia Jordan University of Science and Technology Alberta Health Services

About

Yazid N. Al Hamarneh is an author at University of Alberta specializing in medicine, public health, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	427
2	Public Health	8	8	379
3	Diabetes	1	1	16
4	Family Medicine	1	1	16
5	Health Behavior	1	1	56

Yazid N. Al Hamarneh

Publications

Citations

H-Index

Page 1

	Year	Citations
The Effectiveness of Pharmacist Interventions on Cardiovascular Risk Ross T. Tsuyuki, Yazid N. Al Hamarneh, Charlotte Jones, Journal of the American College of Cardiology Non-pharmacological InterventionHypertensionCardiovascular DiseaseCardiovascular RiskPharmacotherapy	2016	192
Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians Tareq L. Mukattash, Mohd Shara, Anan S. Jarab, International Journal of Pharmacy Practice	2012	97
Pharmacist intervention for glycaemic control in the community (the RxING study) Yazid N. Al Hamarneh, Theresa L. Charrois, Richard Lewanczuk, BMJ Open	2013	97
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria Geoff D.E. Cuvelier, Eneida R. Nemecek, Justin T. Wahlstrom, Blood	2019	87
Patient, family physician and community pharmacist perspectives on expanded pharmacy scope of practice: a qualitative study Maoliosa Donald, Kathryn King‐Shier, Ross T. Tsuyuki, CMAJ Open	2017	67
Coronary heart disease: health knowledge and behaviour Yazid N. Al Hamarneh, Grainne Crealey, James C. McElnay International Journal of Clinical Pharmacy Cardiovascular DiseaseHealth CommunicationCoronary UnitHealth PromotionHealth Behavior	2011	56
The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial Yazid N. Al Hamarneh, Brenda R. Hemmelgarn, Charlotte Jones, Canadian Journal of Diabetes	2017	44
Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the R<sub>x</sub>EACH study Yazid N. Al Hamarneh, Karissa Johnston, Carlo A. Marra, Canadian Pharmacists Journal / Revue des Pharmaciens du Canada	2019	34
Community pharmacist targeted screening for chronic kidney disease Yazid N. Al Hamarneh, Brenda R. Hemmelgarn, Craig Curtis, Canadian Pharmacists Journal / Revue des Pharmaciens du Canada Glomerular DiseaseRenal PathologyRenal InflammationGlomerulonephritisRenal Function	2015	32
Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled RxEACH Trial Yazid N. Al Hamarneh, Ross T. Tsuyuki, Charlotte Jones, American Journal of Kidney Diseases	2017	32

Page 1